Drug
PX-866 clinical trials
Also written PX-866.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
7 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 2
Cascadian Therapeutics Inc. (5) · NCIC Clinical Trials Group (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses PX-866 is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or ProgressionCompletedPhase 2NCIC Clinical Trials GroupNCT01259869Written as PX-866
- A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate CancerCompletedPhase 2NCIC Clinical Trials GroupNCT01331083Written as PX-866
- Study of the Pharmacokinetics and Pharmacodynamics of Crystalline PX-866 Tablets and Amorphous PX-866 Capsules in Healthy VolunteersCompletedPhase 1Cascadian Therapeutics Inc.NCT01408316Written as PX-866
- Phase I Trial of Oral PX-866CompletedPhase 1Cascadian Therapeutics Inc.NCT00726583Written as PX-866
- Study of PX-866 and Docetaxel in Solid TumorsCompletedPhase 1/2Cascadian Therapeutics Inc.NCT01204099Written as PX-866
- Phase 1 and 2 Study of PX-866 and CetuximabCompletedPhase 1/2Cascadian Therapeutics Inc.NCT01252628Written as PX-866 (SCCHN)
- Study of PX-866 and Vemurafenib in Patients With Advanced MelanomaTerminatedPhase 1/2Cascadian Therapeutics Inc.NCT01616199Written as PX-866